Scholars Central

CommentaryPublished 10 Nov 2022

Current Treatment Strategy for Intraductal Papillary Mucinous Neoplasms (IPMNs)

Authors: Ming Yim

Journal of the Pancreas

Volume 23 · Issue 11 · Pages 110–111

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

An intraductal papillary mucinous neoplasm (IPMN) is a benign pancreatic cyst that can turn malignant, or cancerous, in the ducts of your pancreas. Not all of these tumours develop into cancer. However, experts believe IPMNs are to blame for pancreatic cancer incidences. Surgery is used to treat malignant IPMNs. IPMNs are pancreatic cystic neoplasms that form within the pancreatic ducts and produce mucin. Because they have the potential to become malignant, it is critical to diagnose and treat them as soon as possible. IPMNs in the pancreas' head or uncinate process are often removed via the Whipple surgery (pancreaticoduodenectomy). In rare cases if the intraductal papillary mucinous tumour encompasses the entire length of the pancreas, a total pancreatectomy (removal of the entire gland) may be indicated

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of the Pancreas.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of the Pancreas
  • SubjectGastroenterology & Hepatology
  • BylineArticles whose byline prints “Ming Yim”